The effects of intravenous dexmedetomidine on spinal hyperbaric ropivacaine anesthesia.
OBJECTIVE
In this study we investigated the effects of intravenously administered dexmedetomidine on the duration of hyperbaric ropivacaine in spinal anesthesia, and the side effects.


METHODS
In a prospective, double-blind study, sixty ASA I-II patients were randomized to two groups of 30 individuals. All patients were administered hyperbaric ropivacaine (22.5 mg) for spinal anesthesia. Intravenous dexmedetomidine was administered in group I for 60 min, physiological saline at the same amount and duration was infused in group II.


RESULTS
Measurements of mean blood pressure before and after the procedure revealed significant decreases in group I compared with group II after 20, 25, and 30 min. The times for two dermatomes regression of the blockade and complete resolution of motor blockade were significantly prolonged in group I. The sedation score in the dexmedetomidine group was significantly increased compared with controls. Atropine requirement was found to be significantly higher in group I than in group II.


CONCLUSIONS
Our results show that intravenously administered dexmedetomidine prolonged the duration of spinal anesthesia, provided sufficient sedation, and had few side effects. Therefore, dexmedetomidine is appropriate during spinal anesthesia, if the anesthesiologist is alert for development of bradycardia.
Elcicek
Kamuran
K
Department of Anesthesiology, Yuzuncu Yil University, Van, Turkey.
Tekin
Murat
M
Kati
Ismail
I
D000328:Adult; D000577:Amides / Q000008:administration & dosage*; D018712:Analgesics, Non-Narcotic / Q000008:administration & dosage*; D000775:Anesthesia, Spinal / Q000009:adverse effects; D000779:Anesthetics, Local / Q000008:administration & dosage*; D020927:Dexmedetomidine / Q000008:administration & dosage*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D000077212:Ropivacaine
D000577:Amides; D018712:Analgesics, Non-Narcotic; D000779:Anesthetics, Local; D020927:Dexmedetomidine; D000077212:Ropivacaine
Br J Anaesth. 2003 Mar;90(3):304-8
12594141
Anesth Analg. 2004 Mar;98(3):835-40, table of contents
14980948
Anesthesiology. 1991 Mar;74(3):581-605
1672060
J Clin Anesth. 1994 May-Jun;6(3):204-11
7914737
Reg Anesth. 1992 Sep-Oct;17(5):283-7
1419942
Anesth Analg. 2001 Jul;93(1):157-61
11429357
Anesthesiology. 1992 Dec;77(6):1134-42
1361311
Drugs Today (Barc). 1999 Mar;35(3):151-7
12973380
FASEB J. 1993 May;7(8):638-44
8500688
Br J Anaesth. 1998 Dec;81(6):970-1
10211030
Clin Pharmacol Ther. 1989 Jul;46(1):33-42
2568211
Anesth Analg. 1996 Mar;82(3):636-40
8623974
Br J Anaesth. 2001 Feb;86(2):241-4
11573667
Anesthesiology. 2004 Apr;100(4):894-904
15087625
Anesthesiology. 2003 Feb;98(2):495-8
12552210
Eur J Surg. 2001 Aug;167(8):563-9
11716440
Can J Anaesth. 2002 Jan;49(1):32-45
11782326
Anesthesiology. 1992 Jun;76(6):906-16
1599111
Acta Anaesthesiol Scand. 1987 Nov;31(8):730-4
3434164
Reg Anesth Pain Med. 2000 Sep-Oct;25(5):502-5
11009236
Anesthesiology. 2000 Sep;93(3):728-34
10969306
Anesthesiology. 1995 Dec;83(6):1162-6
8533907
Anesth Analg. 1996 Feb;82(2):225-30
8561317
Acta Anaesthesiol Scand. 2006 Feb;50(2):222-7
16430546
Acta Anaesthesiol Scand. 2003 Sep;47(8):1001-5
12904193
Br J Anaesth. 2004 Apr;92(4):547-51
14766715